Immunocytochemical p63 expression discriminates between primary cutaneous follicle centre cell and diffuse large B cell lymphoma‐leg type, and is of the TAp63 isoform
Authors:
- 1 March 2016
- journal article
- Published by Wiley in Histopathology
- Vol. 69 (1) , 11-19
Abstract
Aims: The p63 gene shares structural and functional homologies with the p53 family of transcriptional activators, but differs in exhibiting a consistent expression pattern in normal tissues. Although p63 is rarely mutated in malignancy studies of primary human tumours and cell lines suggest that p63 may promote tumour development. In non‐Hodgkin's nodal lymphoma, TAp63 expression in follicular lymphoma (54%) and diffuse large B cell lymphoma (34%) has been described and correlated with the proliferative index. In this study, we analysed a series of primary cutaneous B cell lymphomas for immunohistochemical expression of p63.Methods and results: Thirty cases of diffuse large B cell lymphoma leg type (pcDLBCLL) and 34 cases of follicle centre cell lymphoma (pcFCCL) were stained using a generic antibody to p63, and a subset of these with an antibody specific for delta‐Np63 isoform. The results indicate a significant difference between pcDLBCLL (21 of 30) and pcFCCL (four of 34) in p63 expression (P = 0.000); expression correlated strongly with the proliferation rate as assessed by Ki‐67 (P = 0.015). None of the p63(+) cases tested expressed the delta‐Np63 isoform, suggesting that expression is of the TAp63 isoform.Conclusions: Functional studies are required to clarify the significance of p63 overexpression in primary cutaneous B cell lymphoma.Keywords
This publication has 31 references indexed in Scilit:
- The Mutational Landscape of Head and Neck Squamous Cell CarcinomaScience, 2011
- p63 Protein expression in high risk diffuse large B-cell lymphomaJournal of Clinical Pathology, 2008
- Clinico‐pathological characteristics of p63 expression in B‐cell lymphomaCancer Science, 2006
- Expression of p63 in Diffuse Large B-Cell LymphomaApplied Immunohistochemistry & Molecular Morphology, 2005
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005
- The transactivating isoforms of p63 are overexpressed in high‐grade follicular lymphomas independent of the occurrence of p63 gene amplificationThe Journal of Pathology, 2005
- Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profilingBlood, 2005
- Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significanceBritish Journal of Dermatology, 2003
- Differential expression of p63 isoforms in normal tissues and neoplastic cellsThe Journal of Pathology, 2002
- AIS is an oncogene amplified in squamous cell carcinomaProceedings of the National Academy of Sciences, 2000